UBS Group AG - NEXIMMUNE INC ownership

NEXIMMUNE INC's ticker is NEXI and the CUSIP is 65344D109. A total of 31 filers reported holding NEXIMMUNE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEXIMMUNE INC
ValueSharesWeighting
Q3 2023$10
-28.6%
490.0%0.00%
Q2 2023$14
-26.3%
490.0%0.00%
Q1 2023$19
-99.5%
49
-99.7%
0.00%
Q4 2022$3,990
-50.1%
16,622
+13.7%
0.00%
Q3 2022$8,000
+100.0%
14,624
+473.7%
0.00%
Q2 2022$4,000
-20.0%
2,549
+106.1%
0.00%
Q1 2022$5,000
-80.8%
1,237
-78.2%
0.00%
Q4 2021$26,000
+44.4%
5,674
+425.4%
0.00%
Q2 2021$18,000
-50.0%
1,080
-42.6%
0.00%
Q1 2021$36,0001,8830.00%
Other shareholders
NEXIMMUNE INC shareholders Q1 2023
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 390,600$81,9870.04%
M28 Capital Management LP 133,442$28,0090.03%
ALLEN OPERATIONS LLC 635,934$133,5460.03%
Slate Path Capital LP 925,000$194,1580.01%
Caprock Group, LLC 103,482$21,7210.00%
WELLS FARGO & COMPANY/MN 126$260.00%
NORTHERN TRUST CORP 12,668$2,6590.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 108,143$21,6280.00%
STATE STREET CORP 22,919$4,5840.00%
View complete list of NEXIMMUNE INC shareholders